Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Margin

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 14.1318.0952.1222.82-5.97

What is the latest Core EBITDA Margin ratio of LYKA LABS ?

The latest Core EBITDA Margin ratio of LYKA LABS is 14.13 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202414.13
Mar202318.09
Mar202252.12
Mar202122.82
Mar2020-5.97

How is Core EBITDA Margin of LYKA LABS Trending?

Years Core EBITDA Margin % Change
Mar2024 14.13
-21.89
Mar2023 18.09
-65.29
Mar2022 52.12
128.40
Mar2021 22.82
Positive
Mar2020 -5.97 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Margin ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹415.4 Cr -2.6% 8.8% 10.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-2.6%

8.8%

10.1%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses